Joanna Ling

939 total citations · 1 hit paper
17 papers, 582 citations indexed

About

Joanna Ling is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Joanna Ling has authored 17 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Joanna Ling's work include Chronic Disease Management Strategies (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Joanna Ling is often cited by papers focused on Chronic Disease Management Strategies (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Joanna Ling collaborates with scholars based in Singapore, United Kingdom and Australia. Joanna Ling's co-authors include David Price, Jaco Voorham, Trung N. Tran, Marjan Kerkhof, Xiao Xu, Frank Trudo, Sanjoy K. Paul, Olga Montvida, Digsu N. Koye and Jill Davis and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and CHEST Journal.

In The Last Decade

Joanna Ling

17 papers receiving 569 citations

Hit Papers

Adverse outcomes from initiation of systemic corticostero... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study
    2018 303 citations David Price, Frank Trudo et al. Journal of Asthma and Allergy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Ling Singapore 10 351 325 72 63 61 17 582
Alida Benfante Italy 13 412 1.2× 422 1.3× 15 0.2× 53 0.8× 34 0.6× 54 590
Nuri Tutar Türkiye 13 136 0.4× 245 0.8× 37 0.5× 70 1.1× 95 1.6× 66 531
Alicia Padilla‐Galo Spain 16 417 1.2× 587 1.8× 6 0.1× 57 0.9× 44 0.7× 54 730
David R. Mink United States 14 565 1.6× 548 1.7× 48 0.7× 51 0.8× 67 1.1× 24 804
Carlos Almonacid Spain 8 147 0.4× 217 0.7× 16 0.2× 30 0.5× 19 0.3× 25 359
Ali Nihat Annakkaya Türkiye 14 87 0.2× 133 0.4× 37 0.5× 67 1.1× 82 1.3× 48 476
Vivian Chia‐Rong Hsieh Taiwan 10 69 0.2× 45 0.1× 24 0.3× 48 0.8× 87 1.4× 36 354
Nathalie Saad Canada 10 160 0.5× 235 0.7× 13 0.2× 25 0.4× 35 0.6× 10 434
Inga Sif Ólafsdóttir Sweden 11 337 1.0× 380 1.2× 30 0.4× 22 0.3× 42 0.7× 17 549
Howraman Meteran Denmark 13 207 0.6× 206 0.6× 10 0.1× 11 0.2× 30 0.5× 40 379

Countries citing papers authored by Joanna Ling

Since Specialization
Citations

This map shows the geographic impact of Joanna Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Ling more than expected).

Fields of papers citing papers by Joanna Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Ling. The network helps show where Joanna Ling may publish in the future.

Co-authorship network of co-authors of Joanna Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Ling. A scholar is included among the top collaborators of Joanna Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Ling. Joanna Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Paul, Sanjoy K., Joanna Ling, Mayukh Samanta, & Olga Montvida. (2022). Robustness of Multiple Imputation Methods for Missing Risk Factor Data from Electronic Medical Records for Observational Studies. PubMed. 6(4). 385–400. 2 indexed citations
2.
3.
Tan, Eugene S.J., Huili Zheng, Joanna Ling, et al.. (2022). Sex and ethnicity modified high 1-year mortality in patients in Singapore with newly diagnosed atrial fibrillation. Annals of the Academy of Medicine Singapore. 51(9). 540–552. 3 indexed citations
4.
Ling, Joanna, Olga Montvida, Kamlesh Khunti, et al.. (2021). Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real‐world evidence from primary care. Diabetes Obesity and Metabolism. 23(7). 1518–1531. 8 indexed citations
5.
Ling, Joanna, Digsu N. Koye, Luke Buizen, et al.. (2021). Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK. Diabetes Obesity and Metabolism. 23(5). 1150–1161. 11 indexed citations
6.
Koye, Digsu N., et al.. (2020). Temporal Trend in Young-Onset Type 2 Diabetes—Macrovascular and Mortality Risk: Study of U.K. Primary Care Electronic Medical Records. Diabetes Care. 43(9). 2208–2216. 28 indexed citations
7.
Fonseca, Mariana, et al.. (2020). The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta‐analysis. Journal of Viral Hepatitis. 27(7). 650–662. 27 indexed citations
8.
Koye, Digsu N., Joanna Ling, Geoffrey D. Cains, et al.. (2020). Treatment modalities and risk of adverse events associated with biologic therapy: A 10‐year observational review of the Australasian Psoriasis Registry. Australasian Journal of Dermatology. 62(1). e47–e54. 4 indexed citations
9.
10.
Chow, Pierce K. H., Le‐Qun Li, Jiangtao Li, et al.. (2019). Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC): Data from HCC registry in Asia.. Journal of Clinical Oncology. 37(4_suppl). 229–229. 2 indexed citations
11.
Park, Hae‐Sim, Dukyong Yoon, Hyun Young Lee, et al.. (2019). Real‐life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred‐dose inhalers in patients with asthma treated with ICS/LABA. Respirology. 24(10). 972–979. 13 indexed citations
12.
Price, David, Frank Trudo, Jaco Voorham, et al.. (2018). Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. Journal of Asthma and Allergy. Volume 11. 193–204. 303 indexed citations breakdown →
13.
Rhee, Chin Kook, Job F. M. van Boven, Hye Yun Park, et al.. (2018). Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation. The Journal of Allergy and Clinical Immunology In Practice. 7(3). 934–942. 12 indexed citations
14.
15.
Voorham, Jaco, Xiao Xu, David Price, et al.. (2018). Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 74(2). 273–283. 73 indexed citations
16.
Price, David, Frank Trudo, Joanna Ling, et al.. (2017). Oral Corticosteroids Increase Risks of Onset of Diabetes Mellitus and Osteoporosis in a UK Patient Population. CHEST Journal. 152(4). A14–A14. 4 indexed citations
17.
Lipworth, Brian J., Derek Skinner, Graham Devereux, et al.. (2016). Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. Heart. 102(23). 1909–1914. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alida Benfante Breakdown of academic impact, for papers by Nuri Tutar Breakdown of academic impact, for papers by Alicia Padilla‐Galo Breakdown of academic impact, for papers by David R. Mink Breakdown of academic impact, for papers by Carlos Almonacid Breakdown of academic impact, for papers by Ali Nihat Annakkaya Breakdown of academic impact, for papers by Vivian Chia‐Rong Hsieh Breakdown of academic impact, for papers by Nathalie Saad Breakdown of academic impact, for papers by Inga Sif Ólafsdóttir Breakdown of academic impact, for papers by Howraman Meteran
Rankless by CCL
2026